-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LVqIMJFIoymQM6xdrSYuHaGFTQq+qIJ15OcI6vePzfYagx/QoE+qX+RCtGgOLapS O/YwXIX0Vw6cCPNFv8LJVA== 0001144204-08-023445.txt : 20080421 0001144204-08-023445.hdr.sgml : 20080421 20080421165717 ACCESSION NUMBER: 0001144204-08-023445 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080418 FILED AS OF DATE: 20080421 DATE AS OF CHANGE: 20080421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLETCHER MARK CENTRAL INDEX KEY: 0001229529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 08767418 BUSINESS ADDRESS: STREET 1: C/O GENEREX BIOTECHNOLOGY CORP STREET 2: 33 HARBOUR SQUARE CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J2G2 4 1 v111276_ex.xml X0202 4 2008-04-18 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001229529 FLETCHER MARK 33 HARBOUR SQUARE STE 202 TORONTO ONTARIO CANADA A1 M5J2G2 BRITISH COLUMBIA, CANADA 0 1 0 0 VP & General Counsel Common Stock 2008-04-18 4 M 0 250000 .89 A 438360 D Common Stock 2008-04-18 4 S 0 100000 1.14 D 338360 D Common Stock 2008-04-18 4 S 0 128342 1.16 D 210018 D Employer Stock Option (right to buy) .89 2008-04-18 4 M 0 250000 0 D 2003-04-21 2008-04-18 Common Stock 250000 0 D /s/ Mark A. Fletcher 2008-04-21 -----END PRIVACY-ENHANCED MESSAGE-----